Bellevue Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-74,525
Closed -$2.21M 168
2023
Q3
$2.21M Sell
74,525
-7,672
-9% -$227K 0.04% 112
2023
Q2
$2.94M Hold
82,197
0.04% 108
2023
Q1
$1.93M Sell
82,197
-53,258
-39% -$1.25M 0.03% 116
2022
Q4
$3.68M Buy
135,455
+73,372
+118% +$2M 0.05% 116
2022
Q3
$3.34M Sell
62,083
-8,497
-12% -$457K 0.05% 114
2022
Q2
$2.85M Sell
70,580
-139,132
-66% -$5.61M 0.04% 120
2022
Q1
$13.9M Sell
209,712
-83,900
-29% -$5.56M 0.16% 102
2021
Q4
$29.4M Sell
293,612
-46,282
-14% -$4.63M 0.3% 88
2021
Q3
$42.5M Sell
339,894
-39,715
-10% -$4.96M 0.43% 73
2021
Q2
$47.1M Buy
379,609
+76,743
+25% +$9.53M 0.46% 69
2021
Q1
$46.2M Buy
302,866
+123,625
+69% +$18.9M 0.49% 65
2020
Q4
$23.1M Buy
179,241
+16,858
+10% +$2.17M 0.26% 95
2020
Q3
$18.2M Buy
162,383
+35,822
+28% +$4M 0.25% 93
2020
Q2
$10.3M Buy
126,561
+21,267
+20% +$1.73M 0.15% 107
2020
Q1
$7.33M Sell
105,294
-4,842
-4% -$337K 0.14% 101
2019
Q4
$8.61M Buy
110,136
+15,375
+16% +$1.2M 0.14% 100
2019
Q3
$6.05M Sell
94,761
-25,087
-21% -$1.6M 0.11% 103
2019
Q2
$10.3M Buy
119,848
+10,196
+9% +$880K 0.18% 84
2019
Q1
$8.41M Buy
109,652
+535
+0.5% +$41K 0.46% 61
2018
Q4
$4.1M Buy
+109,117
New +$4.1M 0.27% 73